Interleukin-2 enhances production in 24 hours of infectious human immunodeficiency virus type 1 in vitro by naturally infected mononuclear cells from seropositive donors
Todd, B.; Pope, J.H.; Georghiou, P.
Archives of Virology 121(1-4): 227-232
1991
ISSN/ISBN: 0304-8608 PMID: 1759906 DOI: 10.1007/bf01316757
Accession: 040474582
When peripheral blood mononuclear cells from HIV-1 seropositive patients were treated with rIL-2 in vitro a rapid increase of 2-12 fold in production of extracellular infectious HIV-1 occurred, in 6 of 9 experiments. Overall, the increase in the 9 experiments was significant (p less than 0.01) and provides more direct evidence for an enhancing role of IL-2 in naturally infected cells.
PDF emailed within 0-6 h: $19.90
Related References
Lucey, D.R.; Pinto, L.A.; Bethke, F.R.; Rusnak, J.; Melcher, G.P.; Hashemi, F.N.; Landay, A.L.; Kessler, H.A.; Paxton, R.J.; Grabstein, K.; Shearer, G.M. 1997: In vitro immunologic and virologic effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients Clinical and Diagnostic Laboratory Immunology 4(1): 43-48Parayath, K.E.; Harrison, T.S.; Levitz, S.M. 2000: Effect of interleukin (IL)-15 priming on IL-12 and interferon-γ production by pathogen-stimulated peripheral blood mononuclear cells from human immunodeficiency virus-seropositive and -seronegative donors The Journal of Infectious Diseases 181(2): 733-736
Haffar, O.K.; Moran, P.A.; Smithgall, M.D.; Diegel, M.L.; Sridhar, P.; Ledbetter, J.A.; Zarling, J.M.; Hu, S.L. 1992: Inhibition of virus production in peripheral blood mononuclear cells from human immunodeficiency virus (HIV) type 1-seropositive donors by treatment with recombinant HIV-like particles Journal of Virology 66(7): 4279-4287
Parayath, K.E.; Harrison, T.S.; Levitz, S.M. 2000: Effect of interleukin (IL)-15 priming on IL-12 and interferon-gamma production by pathogen-stimulated peripheral blood mononuclear cells from human immunodeficiency virus-seropositive and -seronegative donors Journal of Infectious Diseases 181(2): 733-736
Prince, H.E.; Czaplicki, C.D. 1989: Preferential loss of Leu 8-, CD45R, HLA-DR+ CD8 cell subsets during in vitro culture of mononuclear cells from human immunodeficiency virus type i (HIV)-seropositive former blood donors Journal of Clinical Immunology 9(5): 421-428
Lucey, D.R.; Bethke, F.R.; Rusnak, J.; Melcher, G.P.; Paxton, R.J.; Grabstein, K.; Shearer, G.M. 1995: Comparison of IL-15 with IL-2 in the production of human immunodeficiency virus from cultured peripheral blood mononuclear cells infected in vitro or from seropositive patients Journal of Investigative Medicine 43(Suppl 2): 367A
Zhang, L.J.; Waters, C.A.; Poisson, L.R.; Estis, L.F.; Crumpacker, C.S. 1997: The interleukin-2 fusion protein, DAB389IL-2, inhibits the development of infectious virus in human immunodeficiency virus type 1-infected human peripheral blood mononuclear cells Journal of Infectious Diseases 175(4): 790-794
Nair, M.P.; Chadha, K.C.; Hewitt, R.G.; Mahajan, S.; Sweet, A.; Schwartz, S.A. 2000: Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients Clinical and Diagnostic Laboratory Immunology 7(1): 96-100
Mhashilkar, A.M.; LaVecchio, J.; Eberhardt, B.; Porter-Brooks, J.; Boisot, S.; Dove, J.H.; Pumphrey, C.; Li, X.; Weissmahr, R.N.; Ring, D.B.; Ramstedt, U.; Marasco, W.A. 1999: Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies Human Gene Therapy 10(9): 1453-1467
Prince, H.E.; Kleinman, S.H.; Maino, V.C.; Jackson, A.L. 1988: In vitro activation of T lymphocytes from human immunodeficiency virus (HIV)-seropositive blood donors. I. Soluble interleukin 2 receptor (IL2R) production parallels cellular IL2R expression and DNA synthesis Journal of Clinical Immunology 8(2): 114-120
Re, M.C.; Furlini, G.; Gibellini, D.; Vignoli, M.; Ramazzotti, E.; Lolli, E.; Ranieri, S.; La Placa, M. 1994: Quantification of human immunodeficiency virus type 1-infected mononuclear cells in peripheral blood of seropositive subjects by newly developed flow cytometry analysis of the product of an in situ PCR assay Journal of Clinical Microbiology 32(9): 2152-2157
Tang, S.; Zhao, J.; Viswanath, R.; Nyambi, P.N.; Redd, A.D.; Dastyar, A.; Spacek, L.A.; Quinn, T.C.; Wang, X.; Wood, O.; Gaddam, D.; Devadas, K.; Hewlett, I.K. 2011: Absence of detectable xenotropic murine leukemia virus-related virus in plasma or peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected blood donors or individuals in Africa Transfusion 51(3): 463-468
Shixing, T.A.N.G.; Jiangqin, Z.H.A.O.; Gaddam, D.; Devadas, K.; Hewlett, I.K.; Viswanath, R.; Nyambi, P.N.; Redd, A.D.; Dastyar, A.; Spacek, L.A.; Quinn, T.C.; Xue, W.A.N.G.; Wood, O. 2011: Absence of detectable xenotropic murine leukemia virus―related virus in plasma or peripheral blood mononuclear cells of human immunodeficiency virus Type 1―infected blood donors or individuals in Africa Transfusion (Philadelphia, Pa) 51(3): 463-468
Choi, H.J.; Dinarello, C.A.; Shapiro, L. 2001: Interleukin-18 inhibits human immunodeficiency virus type 1 production in peripheral blood mononuclear cells Journal of Infectious Diseases 184(5): 560-568
Haffar, O.K.; Smithgall, M.D.; Bradshaw, J.; Brady, B.; Damle, N.K.; Linsley, P.S. 1993: Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors Proceedings of the National Academy of Sciences of the United States of America 90(23): 11094-11098
Ho, J.L.; He, S.; Hu, A.; Geng, J.; Basile, F.G.; Almeida, M.G.; Saito, A.Y.; Laurence, J.; Johnson, W.D. 1995: Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis Journal of Experimental Medicine 181(4): 1493-1505
Reimann, K.A.; Chernoff, M.; Wilkening, C.L.; Nickerson, C.E.; Landay, A.L. 2000: Preservation of Lymphocyte Immunophenotype and Proliferative Responses in Cryopreserved Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus Type 1-Infected Donors: Implications for Multicenter Clinical Trials Clinical and Vaccine Immunology 7(3): 352-359
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 1995: Neutrophils from human immunodeficiency virus (Hiv)-seronegative donors induce Hiv replication from Hiv-infected patients' mononuclear cells and cell lines: an in vitro model of Hiv transmission facilitated by Chlamydia trachomatis The Journal of Experimental Medicine 181(4): 1493-1505
Alberto Bergamini, E.F.,F.B.,S.G.,L.C.,I.U.,F.D.,M.C.,R.C.,R.P.,S. 1999: Enhanced Production of Tumor Necrosis Factor- and Interleukin-6 Due to Prolonged Response to Lipopolysaccharide in Human Macrophages Infected in vitro with Human Immunodeficiency Virus Type 1 The Journal of Infectious Diseases 179(4): 832-842
Hanon, E.; Goon, P.; Taylor, G.P.; Hasegawa, H.; Tanaka, Y.; Weber, J.N.; Bangham, C.R. 2001: High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells Blood 98(3): 721-726